How should an incidentally discovered empty sella be evaluated and managed?

Incidentally Discovered Empty Sella: Evaluation and Management

All patients with incidentally discovered empty sella should undergo comprehensive pituitary hormone testing at baseline, as approximately 29% will have at least one hormonal axis deficiency, even without symptoms. 1

Initial Hormonal Evaluation

Perform baseline screening for all patients regardless of symptoms, as the absence of clinical symptoms does not reliably predict pituitary function. The 2025 Pituitary Society guidelines explicitly recommend testing for:

• Morning cortisol and ACTH (with dynamic testing if morning cortisol suggests hypocortisolism)
• Free T4 and TSH
• Prolactin
• IGF-1
• LH, FSH, and sex hormones (testosterone in men; estradiol in women as needed)
  • Exception: Premenopausal women with regular menses do not require gonadal testing 1

This comprehensive approach is critical because hypopituitarism rates in incidentally discovered empty sella reach 29%, with specific deficiencies including:

• Hypothyroidism: 2.8%
• Hypogonadism: 8.5%
• Hypocortisolism: 13.5%
• Growth hormone deficiency: 12.5%
• Hyperprolactinemia: 2.9% 1

Risk Stratification

Higher-risk patients require more vigilant monitoring:

• Male sex (P = 0.02)
• History of traumatic brain injury (P = 0.003)
• Total empty sella (higher risk than partial empty sella)
• Progression from partial to total empty sella (associated with hormonal deterioration, P = 0.006) 1

Follow-Up Strategy

For patients with normal baseline pituitary function:

• Recent evidence suggests the risk of developing new hypopituitarism during follow-up is very low 2
• No routine hormonal surveillance is justified if initial testing is normal
• Repeat testing only if new clinical symptoms develop (fatigue, weight changes, menstrual irregularities, decreased libido, cold intolerance)

For patients with documented hormone deficiencies:

• Follow current endocrine society guidelines for specific hormone replacement
• Monitor for progression, particularly if partial empty sella evolves to total empty sella 1

Imaging Considerations

No routine follow-up imaging is required for stable empty sella without mass lesions or other concerning features. The empty sella itself is a static anatomical finding that does not require radiological surveillance unless:

• New neurological symptoms develop
• Visual changes occur
• There is concern for an underlying mass lesion

Critical Pitfalls to Avoid

1. Do not assume asymptomatic means normal pituitary function - Nearly one-third of incidentally discovered cases have hormonal deficiencies 1

2. Do not order serial imaging without clinical indication - Unlike pituitary adenomas, empty sella does not require radiological surveillance

3. Do not perform dynamic GH testing initially - Reserve this for select patients after correcting other pituitary hormone deficiencies 1

4. Do not dismiss symptoms as unrelated - Subtle symptoms of hypopituitarism (fatigue, weight gain, cognitive changes) are often attributed to other causes

When to Refer to Endocrinology

Immediate referral is warranted for:

• Any documented hormonal deficiency requiring replacement therapy
• Uncertain interpretation of borderline hormone results
• Male patients (higher risk profile)
• Patients with traumatic brain injury history
• Total empty sella on imaging

The key distinction: Unlike pituitary adenomas that require ongoing surveillance, incidentally discovered empty sella with normal baseline hormonal function requires no routine follow-up - only symptom-triggered re-evaluation. 2 This represents a significant departure from the management of other pituitary incidentalomas and prevents unnecessary healthcare utilization while maintaining patient safety.